https://link.springer.com/article/10.1007/s00011-022-01661-4
https://acrabstracts.org/abstract/an-open-label-study-to-evaluate-the-effect-of-intra-articular-triamcinolone-acetonide-extended-release-on-patients-with-baseline-synovitis-and-osteoarthritis-of-the-knee/
Thanks Mozz for your great post. I found out these after searching PAR and Dr Kraus, one published in 2021, one published in Oct 2022, Dr Kraus must be our paid consultant at least from 2021 until now.
PAR and the Leading Lady, page-16
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.010(5.00%) |
Mkt cap ! $73.48M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 23.5¢ | 20.0¢ | $1.067M | 4.986M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1519 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 59999 | 2 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |